{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:03:11Z","timestamp":1787306591613,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2015\/19\/N\/NZ5\/02262"],"award-info":[{"award-number":["2015\/19\/N\/NZ5\/02262"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["Marie Curie CIG (Nr 631773)"],"award-info":[{"award-number":["Marie Curie CIG (Nr 631773)"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["International Senior Research Fellowship"],"award-info":[{"award-number":["International Senior Research Fellowship"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/13\/5\/30177"],"award-info":[{"award-number":["RE\/13\/5\/30177"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ankylosing spondylitis (AS) is associated with high cardiovascular morbidity and mortality. Recent studies indicate that microvascular dysfunction may underlie cardiovascular risk in AS. We hypothesized, that microvascular morphology and dysfunction is linked to AS activity and is modifiable by TNF-\u03b1 inhibitor (TNFi) treatment. Functional Laser Doppler Flowmetry with post-occlusive reactive hyperemia, and structural nailfold capillaroscopy were performed in 54 patients with AS and 28 matched controls. Active AS was diagnosed based on BASDAI\u2009\u2265\u20094 (n\u2009=\u200937). Effects of 3-month TNFi on microcirculation in active AS were studied. AS was associated with prolonged time to peak hyperemia compared to healthy controls. High disease activity was associated with increased time to peak hyperemia and decreased peak hyperemia when compared to patients with inactive AS. In capillaroscopy, AS was associated with morphological abnormalities indicating increased neoangiogenesis and pericapillary edema compared to controls. Microvascular function improved following 3 months of TNFi in reference to basal flow as well as post-occlusive parameters. TNFi reduced pericapillary edema, while other parameters of capillary morphology remained unchanged. Microvascular dysfunction and capillary neovascular formation are associated with disease activity of AS. Anti-TNF-\u03b1 treatment may restore microcirculation function and capillary edema but does not modify microvascular structural parameters.<\/jats:p>","DOI":"10.1038\/s41598-018-31550-y","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T17:02:35Z","timestamp":1535562155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment"],"prefix":"10.1038","volume":"8","author":[{"given":"Bogdan","family":"Batko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Maga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7647-9770","authenticated-orcid":false,"given":"Karol","family":"Urbanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ryszawa-Mrozek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Schramm-Luc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2635-0776","authenticated-orcid":false,"given":"Mateusz","family":"Koziej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Mikolajczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilidh","family":"McGinnigle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Czesnikiewicz-Guzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ceranowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz J.","family":"Guzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"31550_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.semarthrit.2014.10.007","volume":"44","author":"S Mathieu","year":"2015","unstructured":"Mathieu, S., Pereira, B. & Soubrier, M. Cardiovascular events in ankylosing spondylitis: an updated meta-analysis. Semin Arthritis Rheum 44, 551\u2013555, https:\/\/doi.org\/10.1016\/j.semarthrit.2014.10.007 (2015).","journal-title":"Semin Arthritis Rheum"},{"key":"31550_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M14-2470","volume":"163","author":"NN Haroon","year":"2015","unstructured":"Haroon, N. N., Paterson, J. M., Li, P., Inman, R. D. & Haroon, N. Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality: A Population-Based Study. Ann Intern Med 163, 409\u2013416, https:\/\/doi.org\/10.7326\/M14-2470 (2015).","journal-title":"Ann Intern Med"},{"key":"31550_CR3","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han, C. et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33, 2167\u20132172 (2006).","journal-title":"J Rheumatol"},{"key":"31550_CR4","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1002\/art.30581","volume":"63","author":"SM Szabo","year":"2011","unstructured":"Szabo, S. M. et al. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum 63, 3294\u20133304, https:\/\/doi.org\/10.1002\/art.30581 (2011).","journal-title":"Arthritis Rheum"},{"key":"31550_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/annrheumdis-2016-209315","volume":"76","author":"JK Eriksson","year":"2017","unstructured":"Eriksson, J. K., Jacobsson, L., Bengtsson, K. & Askling, J. Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? Ann Rheum Dis 76, 364\u2013370, https:\/\/doi.org\/10.1136\/annrheumdis-2016-209315 (2017).","journal-title":"Ann Rheum Dis"},{"key":"31550_CR6","doi-asserted-by":"publisher","first-page":"E85","DOI":"10.1161\/01.RES.86.9.e85","volume":"86","author":"TJ Guzik","year":"2000","unstructured":"Guzik, T. J. et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 86, E85\u201390 (2000).","journal-title":"Circ Res"},{"key":"31550_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","volume":"34","author":"B Messner","year":"2014","unstructured":"Messner, B. & Bernhard, D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol 34, 509\u2013515, https:\/\/doi.org\/10.1161\/ATVBAHA.113.300156 (2014).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"31550_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2010.03.048","volume":"636","author":"Z Fatehi-Hassanabad","year":"2010","unstructured":"Fatehi-Hassanabad, Z., Chan, C. B. & Furman, B. L. Reactive oxygen species and endothelial function in diabetes. European journal of pharmacology 636, 8\u201317, https:\/\/doi.org\/10.1016\/j.ejphar.2010.03.048 (2010).","journal-title":"European journal of pharmacology"},{"key":"31550_CR9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.114.03575","volume":"64","author":"RP Brandes","year":"2014","unstructured":"Brandes, R. P. Endothelial dysfunction and hypertension. Hypertension 64, 924\u2013928, https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03575 (2014).","journal-title":"Hypertension"},{"key":"31550_CR10","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1096\/fj.201500088R","volume":"30","author":"TP Mikolajczyk","year":"2016","unstructured":"Mikolajczyk, T. P. et al. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. FASEB J 30, 1987\u20131999, https:\/\/doi.org\/10.1096\/fj.201500088R (2016).","journal-title":"FASEB J"},{"key":"31550_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3899\/jrheum.100668","volume":"38","author":"N Bodn\u00e1r","year":"2011","unstructured":"Bodn\u00e1r, N. et al. Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol 38, 723\u2013729, https:\/\/doi.org\/10.3899\/jrheum.100668 (2011).","journal-title":"J Rheumatol"},{"key":"31550_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3899\/jrheum.090667","volume":"37","author":"MJ Peters","year":"2010","unstructured":"Peters, M. J. et al. Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol 37, 161\u2013166, https:\/\/doi.org\/10.3899\/jrheum.090667 (2010).","journal-title":"J Rheumatol"},{"key":"31550_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/cvr\/cvv147","volume":"107","author":"T Gerhardt","year":"2015","unstructured":"Gerhardt, T. & Ley, K. Monocyte trafficking across the vessel wall. Cardiovasc Res 107, 321\u2013330, https:\/\/doi.org\/10.1093\/cvr\/cvv147 (2015).","journal-title":"Cardiovasc Res"},{"key":"31550_CR14","doi-asserted-by":"publisher","unstructured":"Nosalski, R. & Guzik, T. J. Perivascular adipose tissue inflammation in vascular disease. Br J Pharmacol, https:\/\/doi.org\/10.1111\/bph.13705 (2017).","DOI":"10.1111\/bph.13705"},{"key":"31550_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/cvr\/cvx093","volume":"113","author":"O Sorop","year":"2017","unstructured":"Sorop, O. et al. The microcirculation: a key player in obesity-associated cardiovascular disease. Cardiovasc Res 113, 1035\u20131045, https:\/\/doi.org\/10.1093\/cvr\/cvx093 (2017).","journal-title":"Cardiovasc Res"},{"key":"31550_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1549-8719.2011.00129.x","volume":"19","author":"M Roustit","year":"2012","unstructured":"Roustit, M. & Cracowski, J. L. Non-invasive assessment of skin microvascular function in humans: an insight into methods. Microcirculation 19, 47\u201364, https:\/\/doi.org\/10.1111\/j.1549-8719.2011.00129.x (2012).","journal-title":"Microcirculation"},{"key":"31550_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/ard.2007.086777","volume":"68","author":"IC van Eijk","year":"2009","unstructured":"van Eijk, I. C. et al. Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade. Ann Rheum Dis 68, 362\u2013366, https:\/\/doi.org\/10.1136\/ard.2007.086777 (2009).","journal-title":"Ann Rheum Dis"},{"key":"31550_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/CH-15112","volume":"65","author":"E Klimek","year":"2017","unstructured":"Klimek, E. et al. Alterations in skin microvascular function in patients with rheumatoid arthritis and ankylosing spondylitis. Clin Hemorheol Microcirc 65, 77\u201391, https:\/\/doi.org\/10.3233\/CH-15112 (2017).","journal-title":"Clin Hemorheol Microcirc"},{"key":"31550_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","volume":"36","author":"JC Mason","year":"2015","unstructured":"Mason, J. C. & Libby, P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J 36, 482\u2013489c, https:\/\/doi.org\/10.1093\/eurheartj\/ehu403 (2015).","journal-title":"Eur Heart J"},{"key":"31550_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters, M. J. et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69, 325\u2013331, https:\/\/doi.org\/10.1136\/ard.2009.113696 (2010).","journal-title":"Ann Rheum Dis"},{"key":"31550_CR21","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1177\/0961203313493031","volume":"22","author":"M Nikpour","year":"2013","unstructured":"Nikpour, M., Gladman, D. D. & Urowitz, M. B. Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand? Lupus 22, 1243\u20131250, https:\/\/doi.org\/10.1177\/0961203313493031 (2013).","journal-title":"Lupus"},{"key":"31550_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0961203315598014","volume":"25","author":"TP Mikolajczyk","year":"2016","unstructured":"Mikolajczyk, T. P. et al. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus. Lupus 25, 18\u201327, https:\/\/doi.org\/10.1177\/0961203315598014 (2016).","journal-title":"Lupus"},{"key":"31550_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jbspin.2010.05.001","volume":"77","author":"S Mathieu","year":"2010","unstructured":"Mathieu, S., Motreff, P. & Soubrier, M. Spondyloarthropathies: an independent cardiovascular risk factor? Joint Bone Spine 77, 542\u2013545, https:\/\/doi.org\/10.1016\/j.jbspin.2010.05.001 (2010).","journal-title":"Joint Bone Spine"},{"key":"31550_CR24","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1136\/ard.2005.050443","volume":"65","author":"VP van Halm","year":"2006","unstructured":"van Halm, V. P. et al. Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 65, 1473\u20131477, https:\/\/doi.org\/10.1136\/ard.2005.050443 (2006).","journal-title":"Ann Rheum Dis"},{"key":"31550_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/cvr\/cvv227","volume":"109","author":"G Passacquale","year":"2016","unstructured":"Passacquale, G., Di Giosia, P. & Ferro, A. The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials. Cardiovasc Res 109, 9\u201323, https:\/\/doi.org\/10.1093\/cvr\/cvv227 (2016).","journal-title":"Cardiovasc Res"},{"key":"31550_CR26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","volume":"162","author":"PM Ridker","year":"2011","unstructured":"Ridker, P. M., Thuren, T., Zalewski, A. & Libby, P. Interleukin-1\u03b2 inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J 162, 597\u2013605, https:\/\/doi.org\/10.1016\/j.ahj.2011.06.012 (2011).","journal-title":"Am Heart J"},{"key":"31550_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/cvr\/cvw089","volume":"111","author":"K Layne","year":"2016","unstructured":"Layne, K., Di Giosia, P., Ferro, A. & Passacquale, G. Anti-platelet drugs attenuate the expansion of circulating CD14 high CD16+ monocytes under pro-inflammatory conditions. Cardiovasc Res 111, 26\u201333, https:\/\/doi.org\/10.1093\/cvr\/cvw089 (2016).","journal-title":"Cardiovasc Res"},{"key":"31550_CR28","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","volume":"37","author":"PM Ridker","year":"2016","unstructured":"Ridker, P. M. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. Eur Heart J 37, 1720\u20131722, https:\/\/doi.org\/10.1093\/eurheartj\/ehw024 (2016).","journal-title":"Eur Heart J"},{"key":"31550_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05759-2","volume":"7","author":"F Ursini","year":"2017","unstructured":"Ursini, F. et al. Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis. Sci Rep 7, 5346, https:\/\/doi.org\/10.1038\/s41598-017-05759-2 (2017).","journal-title":"Sci Rep"},{"key":"31550_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10571-015-0308-1","volume":"36","author":"TM De Silva","year":"2016","unstructured":"De Silva, T. M. & Faraci, F. M. M. Dysfunction and Cognitive Impairment. Cell Mol Neurobiol 36, 241\u2013258, https:\/\/doi.org\/10.1007\/s10571-015-0308-1 (2016).","journal-title":"Cell Mol Neurobiol"},{"key":"31550_CR31","doi-asserted-by":"publisher","unstructured":"Waddingham, M. T. & Paulus, W. J. Microvascular Paradigm in Heart Failure With Preserved Ejection Fraction: A Quest for Proof of Concept. Circ Heart Fail 10, https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004179 (2017).","DOI":"10.1161\/CIRCHEARTFAILURE.117.004179"},{"key":"31550_CR32","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/eurheartj\/ehw018","volume":"37","author":"A Faccini","year":"2016","unstructured":"Faccini, A., Kaski, J. C. & Camici, P. G. Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases. Eur Heart J 37, 1799\u20131806, https:\/\/doi.org\/10.1093\/eurheartj\/ehw018 (2016).","journal-title":"Eur Heart J"},{"key":"31550_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nrrheum.2012.16","volume":"8","author":"G Kerekes","year":"2012","unstructured":"Kerekes, G. et al. Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol 8, 224\u2013234, https:\/\/doi.org\/10.1038\/nrrheum.2012.16 (2012).","journal-title":"Nat Rev Rheumatol"},{"key":"31550_CR34","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.3899\/jrheum.150316","volume":"42","author":"A Arida","year":"2015","unstructured":"Arida, A. et al. Subclinical Atherosclerosis Is Not Accelerated in Patients with Ankylosing Spondylitis with Low Disease Activity: New Data and Metaanalysis of Published Studies. J Rheumatol 42, 2098\u20132105, https:\/\/doi.org\/10.3899\/jrheum.150316 (2015).","journal-title":"J Rheumatol"},{"key":"31550_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/annrheumdis-2013-203934","volume":"74","author":"AM van Sijl","year":"2015","unstructured":"van Sijl, A. M. et al. Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis. Ann Rheum Dis 74, 119\u2013123, https:\/\/doi.org\/10.1136\/annrheumdis-2013-203934 (2015).","journal-title":"Ann Rheum Dis"},{"key":"31550_CR36","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/rheumatology\/ket469","volume":"53","author":"LS Tam","year":"2014","unstructured":"Tam, L. S. et al. The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis\u2014a randomized, placebo-controlled pilot trial. Rheumatology (Oxford) 53, 1065\u20131074, https:\/\/doi.org\/10.1093\/rheumatology\/ket469 (2014).","journal-title":"Rheumatology (Oxford)"},{"key":"31550_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1468-3083.2004.00853.x","volume":"18","author":"Z Nagy","year":"2004","unstructured":"Nagy, Z. & Czirj\u00e1k, L. Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud\u2019s disease. J Eur Acad Dermatol Venereol 18, 62\u201368 (2004).","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"31550_CR38","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/rheumatology\/38.9.826","volume":"38","author":"M Tektonidou","year":"1999","unstructured":"Tektonidou, M., Kaskani, E., Skopouli, F. N. & Moutsopoulos, H. M. Microvascular abnormalities in Sj\u00f6gren\u2019s syndrome: nailfold capillaroscopy. Rheumatology (Oxford) 38, 826\u2013830 (1999).","journal-title":"Rheumatology (Oxford)"},{"key":"31550_CR39","doi-asserted-by":"publisher","first-page":"e001267","DOI":"10.1161\/JAHA.114.001267","volume":"3","author":"PY Hsue","year":"2014","unstructured":"Hsue, P. Y. et al. Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis. J Am Heart Assoc 3, e001267, https:\/\/doi.org\/10.1161\/JAHA.114.001267 (2014).","journal-title":"J Am Heart Assoc"},{"key":"31550_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden, S., Valkenburg, H. A. & Cats, A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27, 361\u2013368 (1984).","journal-title":"Arthritis Rheum"},{"key":"31550_CR41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/ard.2005.040758","volume":"65","author":"J Braun","year":"2006","unstructured":"Braun, J. et al. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65, 316\u2013320, https:\/\/doi.org\/10.1136\/ard.2005.040758 (2006).","journal-title":"Ann Rheum Dis"},{"key":"31550_CR42","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.berh.2008.09.001","volume":"22","author":"M Cutolo","year":"2008","unstructured":"Cutolo, M., Pizzorni, C., Secchi, M. E. & Sulli, A. Capillaroscopy. Best Pract Res Clin Rheumatol 22, 1093\u20131108, https:\/\/doi.org\/10.1016\/j.berh.2008.09.001 (2008).","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"31550_CR43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.20452\/pamw.1879","volume":"123","author":"G Wilk","year":"2013","unstructured":"Wilk, G. et al. Endothelial function assessment in atherosclerosis: comparison of brachial artery flow-mediated vasodilation and peripheral arterial tonometry. Pol Arch Med Wewn 123, 443\u2013452 (2013).","journal-title":"Pol Arch Med Wewn"},{"key":"31550_CR44","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/ard.2007.079756","volume":"67","author":"A Sulli","year":"2008","unstructured":"Sulli, A., Secchi, M. E., Pizzorni, C. & Cutolo, M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 67, 885\u2013887, https:\/\/doi.org\/10.1136\/ard.2007.079756 (2008).","journal-title":"Ann Rheum Dis"},{"key":"31550_CR45","doi-asserted-by":"publisher","unstructured":"Maga, P. et al. Postocclusive Hyperemia Measured with Laser Doppler Flowmetry and Transcutaneous Oxygen Tension in the Diagnosis of Primary Raynaud\u2019s Phenomenon: A Prospective, Controlled Study. BioMed Research International 2016, https:\/\/doi.org\/10.1155\/2016\/9645705 (2016).","DOI":"10.1155\/2016\/9645705"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31550-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31550-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31550-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:23:19Z","timestamp":1751822599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31550-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31550"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31550-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"19 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Batko has consulting and speaker fees from Pfizer, AbbVie, MSD. He has research grants from Pfizer, MSD. The other authors declare no potential conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13205"}}